文献速递生殖医学

单基因男性不育共病检测的临床方案框架

A clinical protocol for the detection of comorbidities associated with monogenic causes of male infertility.
PubMed 文献 · Hum Reprod · 2026-01-01

研究提出一个由七个连续步骤组成的框架,用于为所有单基因男性不育病因生成基因特异性表型分析方案。该框架基于基因在人体组织中的表达模式和文献检索设计定制问卷与检测,并应用于MEI1和DNAH17基因突变的两位男性,未发现当前临床相关异常。

要点

  • 七步框架可系统生成单基因男性不育的基因特异性表型分析方案。
  • 基因表达模式用于识别高表达组织以指导共病筛查。
  • MEI1和DNAH17案例中未发现当前临床相关共病。

核心结论

  • 通过七步框架可为所有单基因男性不育病因生成基因特异性表型分析方案,以系统识别相关共病。

研究设计与样本

  • 研究开发了一个框架并应用于两名不同单基因不育病因的男性,由多学科医学团队制定七个连续步骤。

主要发现

  • 基因表达分析识别MEI1在免疫细胞高表达,DNAH17在视网膜细胞和少突胶质细胞高表达。
  • MEI1参与者的问卷未提示感染、过敏或自身免疫病易感性增加,免疫分析未见临床相关改变。
  • DNAH17参与者的问卷未提示视觉问题,视网膜细胞功能评估和影像未见临床相关改变。

关键数值与推荐

  • 框架包含七个连续步骤,利用基因表达模式和文献检索设计定制问卷与检测。

临床怎么用

  • 临床医生可依据共病是否存在为患者及其未来子代提供额外健康风险咨询,将不育诊疗延伸至一般健康。

局限性

  • 所用Human Protein Atlas数据库仅含成人组织表达数据,可能遗漏基因发育功能相关共病。
  • 共病可能在生命后期出现,表型分析时可能不存在。
  • 需更多相同单基因病因男性进行表型分析以确认真实共病。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: How can comorbidities associated with monogenic forms of male infertility systematically be identified? SUMMARY ANSWER: Via a framework that consists of seven sequential steps, gene-specific phenotyping protocols can be generated for all monogenic causes of male infertility. WHAT IS KNOWN ALREADY: Infertility negatively impacts men's health. When loss of a single gene is causal for infertility (i.e. monogenic), the associated comorbidities are largely unknown. STUDY DESIGN, SIZE, DURATION: A framework was developed that allows the generation of gene-specific phenotyping protocols. The framework was applied to generate such protocols for two men, each with a different monogenic cause for their infertility. PARTICIPANTS/MATERIALS, SETTING, METHODS: A multidisciplinary medical team formulated seven sequential steps to develop gene-specific phenotyping protocols. Gene-specificity was obtained by using a gene's expression pattern in the human body to identify tissues/cell types that show high levels of expression, as well as a literature search on the gene of interest, for potential morbidities. With these insights, tailored questionaries and tests are designed. We applied this framework to generate gene-specific protocols for two men in whom infertility was caused by the respective disruption of the genes MEI1 and DNAH17. These genes respectively show very high levels of expression in various types of immune cells and retinal cells. With gene-specific phenotyping protocols, we assessed the functionality of these cells in these men. MAIN RESULTS AND THE ROLE OF CHANCE: Our framework facilitated the generation of two gene-specific phenotyping protocols that were used to systematically identify potential comorbidities associated with two forms of monogenic male infertility. Analyses of the gene expression in the human body identified immune cells (MEI1) and retinal cells and oligodendrocytes (DNAH17) as somatic cell types with high expression. Gene-specific phenotyping protocols contained targeted questions as well as clinical tests for these tissues/cell types. The questionnaires indicated no increased susceptibility to infections, allergies nor autoimmune disease (MEI1) or visual problems (DNAH17). The clinical tests comprised extensive immune profiling for the MEI1-participant and functional evaluation and imaging of the retinal cells of the DNAH17-participant. None of the test results indicated clinically relevant alterations at present. To identify true comorbidities, or lack thereof, more men with the same monogenic cause should be phenotyped. LARGE SCALE DATA: Not applicable. LIMITATIONS, REASONS FOR CAUTION: The Human Protein Atlas database was used to assess the expression pattern of the causal gene. This database only contains expression data in adult tissues. Potential comorbidities due to a developmental function of a gene can therefore be missed. In addition, comorbidities might develop later in life and might not be present during the phenotyping. WIDER IMPLICATIONS OF THE FINDINGS: Knowledge on the presence or absence of infertility-associated comorbidities allows clinicians to counsel patients on possible additional health risks for themselves and potential future offspring. As a consequence, medical care for infertile people extends beyond reproductive needs to general health. STUDY FUNDING/COMPETING INTEREST(S): J.A.V. was funded by an Investigator Award in Science from the Wellcome Trust (209451) and by The Netherlands Organization for Scientific Research (918-15-667). The authors declare no conflicts of interest. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. van der Heijden GW, Westra D, van Olden MCS, et al. A clinical protocol for the detection of comorbidities associated with monogenic causes of male infertility. Hum Reprod. 2026. PMID: 41863311. doi:10.1093/humrep/deag038

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。